Brochure
25 Sep 2024
Mabion - Your Biologics CDMO Partner: Drug Substance Manufacturing, Process Development, Analytics, Fill & Finish
PDF 2.2 MB
With a comprehensive panel of services and fully integrated solutions, Mabion is ready to become your CDMO partner for the entire development journey from pre-clinical to GMP manufacturing. Our end-to-end offer covers every stage of this process, from gene synthesis to the final product release. With Mabion’s expertise and comprehensive services, we can bring your biologic to market rapidly and robustly.
Content provided by our supplier
Mabion SA
-
PL -
2023On CPHI since
-
3Certificates
-
250 - 499Employees
Company types
Primary activities
Other Content from Mabion SA (1)
-
News Development and regulation of veterinary monoclonals
Simarly to the drugs for human use, veterinary drugs must pass a strict registration procedure, both in the EU and US realms – sponsoring companies must present comprehensive evidence that they are safe and effective for use. While in the EU veterinary mAbs are approved by the EMA, in the U.S. these products are evaluated either by FDA or USDA (U.S. Department of Agriculture), depending on the intended indication.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance